Basic Information
ID: ALA4672558
Type: Toxicity
Description: Therapeutic index, ratio of average IC50 for human MRC5 and BJ cells to IC50 for antileishmanial activity against Leishmania major
Activity Charts
Bioactivity
Activity Types for Assay ALA4672558
TI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 924.09 | 0.71 | 0.71 |
| 407.58 | 5.68 | 5.68 |
| 395.46 | 3.92 | 3.92 |
| 396.90 | 4.82 | 4.82 |
| 452.54 | 5.03 | 5.03 |
| 449.49 | 5.13 | 5.13 |
| 368.85 | 4.04 | 4.04 |
| 441.35 | 4.93 | 4.93 |
| 457.35 | 3.90 | 3.90 |
| 500.63 | 3.61 | 3.61 |
| 470.53 | 5.17 | 5.17 |
| 420.49 | 3.71 | 3.71 |
| 427.33 | 4.54 | 4.54 |
| 301.40 | 3.55 | 3.55 |
| 412.90 | 3.79 | 3.79 |
| 407.46 | 4.07 | 4.07 |
| 362.46 | 4.17 | 4.17 |
| 334.40 | 3.39 | 3.39 |
| 348.43 | 3.78 | 3.78 |
| 438.94 | 5.88 | 5.88 |
| 578.57 | 6.33 | 6.33 |
| 402.59 | 4.95 | 4.95 |
| 526.54 | 5.83 | 5.83 |
| 448.94 | 5.55 | 5.55 |
| 481.67 | 3.60 | 3.60 |
| 470.58 | 5.97 | 5.97 |
| 441.57 | 5.09 | 5.09 |
| 322.50 | 4.23 | 4.23 |
| 419.55 | 3.43 | 3.43 |
| 302.31 | 2.74 | 2.74 |
| 470.58 | 5.97 | 5.97 |